Where does Shanghai Reach Medical Instrument Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Shanghai Reach Medical Instrument Co., Ltd. ranks #42,943 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Shanghai Reach Medical Instrument Co., Ltd. hold?

Shanghai Reach Medical Instrument Co., Ltd. holds 6 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Shanghai Reach Medical Instrument Co., Ltd.'s Innovation Score?

Shanghai Reach Medical Instrument Co., Ltd. has an Innovation Score of 25.1 out of 100 (16th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Shanghai Reach Medical Instrument Co., Ltd. focus on?

Shanghai Reach Medical Instrument Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents, ranking #3,118 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Shanghai Reach Medical Instrument Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Shanghai Reach Medical Instrument Co., Ltd..

What does claim depth mean for Shanghai Reach Medical Instrument Co., Ltd.'s patents?

Shanghai Reach Medical Instrument Co., Ltd.'s patents average 10.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Shanghai Reach Medical Instrument Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Reach Medical Instrument Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Shanghai ranks #42,943 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#42,943
of 49,997 US assignees by volume: 16th percentile
by Innovation Score (25.1/100): 10.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R42943 · Foreign Corporation #42,943 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #42,943/49,997
PHOTO-FINISH Shanghai dpdupi…
CPC-NARROW A61B · 5 areas
INNOV-THIN 25.1/100
CLAIMS-PAR 10.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Shanghai dpdupi lighting electrical co. Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanghai’s 25.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (27%) Velocity 4.4 pts (18%) Breadth 7.9 pts (32%) Claim depth 6.0 pts (24%)

Qualcomm Incorporated · highest

85
Shanghai Reach… · this assignee

25
3D Lighting… · lowest

7

What this shows Shanghai's Innovation Score is 25.1/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Shanghai?

Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 10.0 claims/patent is ABOVE the 8.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanghai's grants concentrate

Shanghai Reach Medical Instrument Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (3 grants) versus a trough of 2 in 2022. By volume, Shanghai sits between Shanghai Lumosa Therapeutics Co., Ltd. and Shanghai dpdupi lighting electrical co. Ltd.

Shanghai's three-year grant acceleration

Shanghai Reach Medical Instrument Co., Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Shanghai Lumosa T…

6
Shanghai Mebania…

6
Shanghai Nanojcle…

6
Shanghai North Oc…

6
Shanghai Townew I…

6
Shanghai Wangmeng…

6
Shanghai Xinshenp…

6
Shanghai dpdupi l…

6
Shanghai Reach Me… ◀

6

What this shows Shanghai holds 6 patents at rank #43,157, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Shanghai

By rank, the assignees closest to #43,157 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Shanghai's primary technology class.

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Shanghai Reach Medical Instrument Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	3	50.0%
2022	2	33.3%
2025partial year	1	16.7%

Which technologies does Shanghai Reach Medical Instrument Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

B27F - Dovetailed WORK; TENONS; Slotting Machines FOR Wood OR Similar MATERIAL; Nailing OR Stapling Machines 1

B25G - Handles FOR Hand Implements 1

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Shanghai Reach Medical Instrument Co., Ltd.'s patent record in context - here's where to go next.

Shanghai Reach Medical Instrument Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 83.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #42,943 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Shanghai Reach Medical Instrument Co., Ltd. against Shanghai Lumosa Therapeutics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.